All Posts Tagged With: "HOLX"
(ISR) IsoRay Begins GliaSite Shipment
Medical isotope maker IsoRay Inc (ISR) said that it has commenced the shipment for its GliaSite radiation therapy system, a balloon catheter used in treating brain cancer.
This follows the recent approval...
(HOLX) Hologic Launches C-View Software
Hologic (HOLX), a leading player in the field of women’s health, has released its C-View synthesized 2D image reconstruction algorithm. This eliminates the requirement of a conventional 2D mammogram as...
(ISR) IsoRay’s GliaSite Gets Final Nod
IsoRay Inc (ISR), which makes the Cesium-131 internal radiation therapy (brachytherapy) isotope, has crossed the last regulatory hurdle for its GliaSite radiation therapy system, a balloon catheter used in...
(HOLX) Hologic Earnings Report Shows Strong Growth
Hologic (HOLX) reported an adjusted EPS of 30 cents during the second quarter of fiscal 2011, surpassing the Zacks Consensus Estimate by 2 cents and a penny above the year-ago quarter. Revenues were $438.7...
(AA) Company News for May 03, 2011 – Corporate Summary
• Arch Coal, Inc. (NYSE:ACI) and International Coal Group, Inc. (NYSE:ICO) announced that they have signed a definitive agreement under which Arch will acquire all...
(HOLX) Hologic’s Report Surpasses Wall Street’s Estimate
Hologic Inc.’s (HOLX) first quarter fiscal 2010 (ended Dec 26, 2009) earnings of 29 cents per share (excluding special items) were above the Zacks Consensus Estimate of 26 cents. The company had earned...
(HOLX) Analysts Upgrade Hologic Pre-Earnings
Recently, we upgraded Hologic, Inc. (HOLX) to Neutral from Underperform with a price target of $16.00.
Even though we are concerned about the strong competition and declining revenues which are largely...
(UNH) Healthcare Stock Review – December 2009 – Industry Outlook
OVERVIEW
The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors...
(HOLX) Hologic, Incorporated – Bear of the Day
Hologic, Inc. (HOLX) reported fourth quarter earnings of 28 cents per share, above the Zacks Consensus Estimate of 26 cents, but a couple of cents below the year-ago earnings. For fiscal 2009, the company...
(HOLX) Hologic Beats Consensus Earnings Estimates
Hologic, Inc. (HOLX) reported fourth-quarter earnings of 28 cents per share, which beat the Zacks Consensus Estimate of 26 cents. The company earned 30 cents in the year-ago quarter. For full fiscal 2009,...
(HOLX) Hologic Breast Cancer Product Gets FDA Nod
Yesterday, the U.S. Food and Drug Administration (FDA) approved a more flexible design of Hologic Inc.’s (HOLX) MammoSite system, which provides radiation seeds to prevent recurrences of breast cancer. The company intends to launch the radiation therapy...